Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Gynecologic 2Genitourinary 2Breast 2Thoracic 1Sarcoma 1Dermatologic 1

Conditions

Vomiting 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Ovarian Neoplasms 1Nasopharyngeal Neoplasms 1Gynecologic Cancer 1

Interventions

Dexamethasone 7Aprepitant 6Ondansetron 4Granisetron 3Calcium Dobesilate 3fosaprepitant 2dexamethasone acetate 2dexamethasone 21-phosphate 2Surveys and Questionnaires 2ramosetron 1netupitant, palosentron drug combination 1auricularum 1Tropisetron 1Sugars 1Saline Solution 1Psychiatric Rehabilitation 1Platinum 1Octreotide 1Massage 1Interviews as Topic 1Immunoenzyme Techniques 1Electroacupuncture 1Cyproheptadine 1Cyclophosphamide 1Cisplatin 1Chemotherapy, Adjuvant 1Carboplatin 1Analgesia 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Vomiting × fosaprepitant × Gynecologic × Clear all
NCT05564286 2024-02-06

Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal Cancer

Shantou University Medical College

Phase 3 Completed
116 enrolled
GynecologicHead & Neck

Uterine Cervical Neoplasms, Nasopharyngeal Neoplasms, Vomiting

NCT01432015 2017-03-28

Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting

Gynecologic Oncology Associates

Phase 4 Completed
20 enrolled 5 charts
Gynecologic

Ovarian Neoplasms, Uterine Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡